Operating Expenses: The sum of all operating expenses for the given industry.
Nanobiotix S.A. - Sponsored ADR (NBTX) had Operating Expenses of $49.12M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$36.88M |
|
$-27.11M |
|
-- |
|
$36.88M |
|
|
Operating Expenses |
$49.12M |
$-12.24M |
|
$-14.87M |
|
$-27.11M |
|
$-27.11M |
|
$-27.11M |
|
$-27.11M |
|
$-27.11M |
|
$-27.11M |
|
$-12.24M |
|
$-10.55M |
|
47.82M |
|
47.82M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$71.00M |
|
$5.17M |
|
$5.67M |
|
$76.66M |
|
$65.06M |
|
-- |
|
$107.18M |
|
$172.25M |
|
$-95.58M |
|
$-95.59M |
|
$-95.58M |
|
48.41M |
|
| Cash Flow Statement Financials | |
$-37.81M |
|
$-0.65M |
|
$42.33M |
|
$56.27M |
|
$59.68M |
|
$3.41M |
|
$4.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-33.19% |
|
-33.19% |
|
-28.60% |
|
-73.51% |
|
-73.52% |
|
$-38.42M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
-- |
|
15.26 |
|
23.92 |
|
28.36% |
|
28.36% |
|
-35.36% |
|
28.36% |
|
$-1.97 |
|
$-0.80 |
|
$-0.79 |
|